536 filings
Page 8 of 27
10-Q
2020 Q1
COCP
Cocrystal Pharma Inc
Quarterly report
13 May 20
4:20pm
CORRESP
COCP
Cocrystal Pharma Inc
12 May 20
Correspondence with SEC
12:00am
8-K
COCP
Cocrystal Pharma Inc
11 May 20
Regulation FD Disclosure
8:30am
CORRESP
COCP
Cocrystal Pharma Inc
11 May 20
Correspondence with SEC
12:00am
S-3/A
COCP
Cocrystal Pharma Inc
Shelf registration (amended)
4 May 20
4:31pm
CORRESP
COCP
Cocrystal Pharma Inc
4 May 20
Correspondence with SEC
12:00am
DEFA14A
COCP
Cocrystal Pharma Inc
28 Apr 20
Additional proxy soliciting materials
4:54pm
DEF 14A
COCP
Cocrystal Pharma Inc
Definitive proxy
28 Apr 20
4:10pm
3
COCP
Cocrystal Pharma Inc
27 Apr 20
Cocrystal Pharma / Roger D. Kornberg ownership change
4:05pm
UPLOAD
COCP
Cocrystal Pharma Inc
27 Apr 20
Letter from SEC
12:00am
8-K
COCP
Cocrystal Pharma Inc
22 Apr 20
Entry into a Material Definitive Agreement
8:05am
8-K
COCP
Cocrystal Pharma Inc
20 Apr 20
Cocrystal Pharma Announces Appointment of Nobel Laureate and Scientific Advisor, Roger D. Kornberg, Ph.D., to Board of Directors
8:05am
S-3
COCP
Cocrystal Pharma Inc
Shelf registration
17 Apr 20
4:42pm
8-K
COCP
Cocrystal Pharma Inc
30 Mar 20
Cocrystal Pharma Reports 2019 Financial Results and Outlines Expected Value-Driving Milestones for 2020
6:10am
10-K
2019 FY
COCP
Cocrystal Pharma Inc
Annual report
27 Mar 20
4:31pm
8-K
COCP
Cocrystal Pharma Inc
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
SC 13D/A
COCP
Cocrystal Pharma Inc
10 Mar 20
Cocrystal Pharma / Opko Health ownership change
4:10pm
424B5
COCP
Cocrystal Pharma Inc
10 Mar 20
Prospectus supplement for primary offering
3:04pm
8-K
COCP
Cocrystal Pharma Inc
9 Mar 20
Cocrystal Pharma Announces Plans to Advance Coronavirus Program
9:27am
SC 13G
COCP
Cocrystal Pharma Inc
6 Mar 20
Beneficial ownership report
9:25am